| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket… | Advanced Solid Tumor | Recruiting |
| NCT06411600 | Combination Therapy for BRAF-V600E Metastatic CRCm | Metastatic Colorectal Cancer | Recruiting |
| NCT06650514 | A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc… | Osteosarcoma | Recruiting |
| NCT06630611 | Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog… | Melanoma | Recruiting |
| NCT06680739 | Single cEll pRofiling PErsistaNce To ImmuNothErapy | Colorectal Cancer | Recruiting |
| NCT03979131 | Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients… | Gastroesophageal Junction Adenocarcinoma | Active, Not Recruiting |
| NCT07178717 | A Study to Characterize Encorafenib Plus Cetuximab as Rechallenge Treatment for BRAF… | Colo-rectal Cancer | Not Yet Recruiting |
| NCT07593040 | Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma | Renal Cell Carcinoma | Not Yet Recruiting |
| Phase 1 | |||
| NCT07593820 | A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the… | Metastatic Gastric Cancer | Recruiting |
| Early Phase 1 | |||
| NCT05141474 | Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected… | Epithelial Tumors, Malignant | Recruiting |
| Not specified | |||
| NCT05916755 | Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast… | Triple Negative Breast Cancer | Recruiting |